Letter to the Editor: The Role of Cannabidiol in Cancer Care: Oncologist and Cancer Patient Perspectives

Manan M Nayak; Peter R Chai; Stephanie Tung; Timothy S Sannes; Miryam Yusufov; Ilana M Braun

doi:10.1089/can.2022.0033

Letter to the Editor: The Role of Cannabidiol in Cancer Care: Oncologist and Cancer Patient Perspectives

Cannabis Cannabinoid Res. 2023 Apr;8(2):381-383. doi: 10.1089/can.2022.0033. Epub 2022 May 4.

Authors

Manan M Nayak^{1

2

3}, Peter R Chai^{1

4

5}, Stephanie Tung^{1

2

6}, Timothy S Sannes^{1

2

6}, Miryam Yusufov^{1

2

6}, Ilana M Braun^{1

2

6}

Affiliations

¹ Harvard Medical School, Boston, Massachusetts, USA.
² Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
³ Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
⁴ Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.
⁵ Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
⁶ Fenway Institute, Boston, Massachusetts, USA.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Cannabidiol* / pharmacology
Cannabidiol* / therapeutic use
Humans
Neoplasms* / drug therapy
Oncologists*

Substances

Cannabidiol

Grants and funding

R01 DA047236/DA/NIDA NIH HHS/United States